Abstract 412: Drug combination screen identifies pemigatinib, an FGFR inhibitor, as a mechanism to overcome KRASG12C inhibitor resistance in lung cancer
Abdollahi, Angela, Favata, Margaret, DiMatteo, Darlise, Schuette, Sean, Boarder, Erika, Rupar, Mark, Macarron, Ricardo, Gilmartin, Aidan, Wang, Hui, Amador-Arjona, Alejandro
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article